| The migration of activated T lymphocytes in vitro. III. Paralysis and recovery of locomotor function during mitosis. | |
| | |
MedLine Citation:
|
PMID: 2935978 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Previous reports have stated that activated lymphocytes are more motile than unsensitized lymphocytes and that certain subpopulations of lymphocytes are more motile than others. In order to determine at what stage of activation lymphocytes become motile, we have examined lymphocyte motility as well as other functions at various times after mitogenic or allogeneic stimulation in culture. Lymphocytes cultured with concanavalin A (Con A) or with alloantigen become most motile after peak thymidine incorporation has occurred. Allosensitized lymphocytes need not possess cytolytic capacity in order to become motile. Allosensitized lymphocytes retain the ability to locomote at near maximal rates for at least 2 weeks after stimulation. When these motile, allosensitized lymphocytes are recultured in the presence of fresh irradiated stimulator cells, they lose their ability to locomote during active thymidine incorporation and become motile again when thymidine incorporation has abated. Lymphocyte clones demonstrated motility cycles similar to cycles observed with bulk cultures (i.e., peak motility is observed only after peak thymidine incorporation has occurred in the subculture). All T lymphocyte clones tested are motile, regardless of Lyt phenotype or function, if tested for motility on the appropriate day of subculture. Studies of clone motility at intervals less than 24 hr after restimulation revealed that motility ceased before tritiated thymidine uptake occurred. The migratory potential of lymphocytes in vitro does not seem to depend on phenotype or the nature of the mitogenic stimulus. It seems instead to be part of the cyclic response of the cell to activation, with early inhibition of motility and subsequent recovery of locomotor function. Whether ability to locomote is intrinsic to the activated cell or depends on environmental factors requires further investigation. |
| | |
Authors:
|
R A Hoffman; B J Hyland; N L Ascher; R L Simmons |
Related Documents
:
|
22078318 - Differential expression of fcrla in naïve and activated mouse b cells. 6606618 - Staphylococcal protein-a is a potent t-cell mitogen of tonsillar lymphocytes. 8964608 - Diacylglycerol and ceramide kinetics in primary cultures of activated t-lymphocytes. 133778 - Enhancement of "one-way" human mixed lymphocyte reaction by cholinergic agents. 22772058 - Immunoglobulin gamma heavy chain gene with somatic hypermutation is frequently expresse... 20623538 - Immunodeficiency reduces neural stem/progenitor cell apoptosis and enhances neurogenesi... |
Publication Detail:
|
Type: Journal Article; Research Support, U.S. Gov't, P.H.S. |
Journal Detail:
|
Title: Transplantation Volume: 41 ISSN: 0041-1337 ISO Abbreviation: Transplantation Publication Date: 1986 Feb |
Date Detail:
|
Created Date: 1986-03-14 Completed Date: 1986-03-14 Revised Date: 2007-11-14 |
Medline Journal Info:
|
Nlm Unique ID: 0132144 Medline TA: Transplantation Country: UNITED STATES |
Other Details:
|
Languages: eng Pagination: 214-20 Citation Subset: IM |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Animals Cell Movement Clone Cells / immunology, physiology Concanavalin A / pharmacology Female Isoantigens / immunology Kinetics Lymph Nodes / cytology Lymphocyte Activation* Lymphocyte Culture Test, Mixed Mice Mice, Inbred BALB C Mice, Inbred C57BL Mice, Inbred DBA Mitosis* T-Lymphocytes / cytology, immunology, physiology* |
| Grant Support | |
ID/Acronym/Agency:
|
AI 16869/AI/NIAID NIH HHS; CA 11605/CA/NCI NIH HHS |
| Chemical | |
Reg. No./Substance:
|
0/Isoantigens; 11028-71-0/Concanavalin A |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Dehydroepiandrosterone (DHEA) measurements in cord blood.
Next Document: Development of a simplified counterflow centrifugation elutriation procedure for depletion of lympho...